These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
544 related items for PubMed ID: 1628126
21. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years. Vesikari T, Baer M, Willems P. Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879 [Abstract] [Full Text] [Related]
22. Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children. Glikmann G, Petersen I, Mordhorst CH. Dan Med Bull; 1988 Apr; 35(2):185-7. PubMed ID: 3359817 [Abstract] [Full Text] [Related]
24. A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection. Frenkel LM, Nielsen K, Garakian A, Cherry JD. Arch Pediatr Adolesc Med; 1994 Jan; 148(1):57-60. PubMed ID: 8143011 [Abstract] [Full Text] [Related]
26. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines. Weibel RE, Buynak EB, McLean AA, Hilleman MR. Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873 [Abstract] [Full Text] [Related]
28. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan. Chiu HH, Lee CY, Chih TW, Lee PI, Chang LY, Lin YJ, Hsu CM, Huang LM. J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946 [Abstract] [Full Text] [Related]
29. [Mumps epidemic in vaccinated children in West Switzerland]. Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D. Schweiz Med Wochenschr; 1997 Jun 28; 127(26):1124-33. PubMed ID: 9312835 [Abstract] [Full Text] [Related]
31. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella. Tischer A, Gerike E. Vaccine; 2000 Jan 31; 18(14):1382-92. PubMed ID: 10618536 [Abstract] [Full Text] [Related]
34. [Responses to triple viral and tetanus vaccination in HIV-infected children]. Echeverría Lecuona J, Aldamiz-Echevarría Azuara L, Cilla Eguiluz G, Pérez Trallero E. An Esp Pediatr; 1996 Apr 31; 44(4):317-20. PubMed ID: 8849078 [Abstract] [Full Text] [Related]
35. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia. Feldman S, Andrew M, Norris M, McIntyre B, Iyer R. Clin Infect Dis; 1998 Aug 31; 27(2):388-90. PubMed ID: 9709893 [Abstract] [Full Text] [Related]
36. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine]. Borcić B, Smerdel S, Abu Eldan J, Kolić J, Ferdebar M, Kordić D, Mohacek N. Lijec Vjesn; 1989 Aug 31; 111(4-5):131-4. PubMed ID: 2770398 [Abstract] [Full Text] [Related]
40. [The clinico-immunological evaluation of a bivalent vaccine against measles and rubella]. Schettini F, Manzionna MM, De Mattia D, Amendola F, Di Bitonto G. Minerva Pediatr; 1990 Dec 31; 42(12):531-6. PubMed ID: 2087226 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]